CONTENTS
About the Report 01
Statement of the Board of Directors 03
Message from the Chairman 04
Environmental Management
Performance Highlight in 2025 05
Environmental Management System 20
About Eyebright Medical 07
Environmental Risk Management 22
Sustainability Management 15
Pollution Prevention
Wastewater Management 24
Waste Gas Management 25
Waste Management 26
Noise Management 27
Resource Management
Water Resource Management 28
Energy Management 28
Green Production 30
Green Office Practices 31
Climate Action
Climate-Related Risks 31
Climate Resilience and Adaptation 33
Greenhouse Gas Emissions 35
Ecosystem and Biodiversity Protection 35
Innovation Empowerment
Scientific Research Framework 37
R&D Investment 38
Recently Introduced Products 38
Intellectual Property Protection 39
Experimental Ethics 40
Collaborative Industry
Advancement
Corporate Governance
Academic Exchange 41
Governance Structure 68
Standard Establishment 43
Board and Management Operations 69
School-Enterprise Cooperation 44
Information Disclosure 70
Training & Empowerment 45
Investor Relations Management 71
Accessibility of Medical Services 47
Investor Returns 72
Product Responsibility Market Capitalization Management 72
Risk Management and
Quality Management 48
Control
Customer Service 49
Sustainable Supply Chain 50
Compliance and Internal Control 73
Employee Development Management
Employee Rights Protection 51 Related Party Transactions and Control 73
Cultivation and Development 52 Management of Public Opinion 74
Welfare and Care 55 Anti-Fraud and Anti-Corruption Measures 74
Occupational Health and Safety 59 Anti-Unfair Competition Practices 75
Reporting Mechanism 75
Serve the Society Information Security & Data Privacy 76
Rural Revitalization 60
International Aid Initiatives 61 Appendix 78
Medical Donations 62
Charity Activities 63
Science Popularization 65
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
About the Report
Report Overview
Eyebright Medical Technology (Beijing) Co., Ltd.
(hereinafter referred to as "Eyebright Medical," "the
Company," or "we") has systematically established an
ESG management framework to achieve an in-depth
integration of shareholder rights protection and
sustainable corporate development.
Report Scope
The scope of this report encompasses Eyebright
Medical and its affiliated subsidiaries.
Reporting Period
This report covers the period from January 1st, 2025,
to December 31st, 2025.
Information Sources
The data used in this report is sourced from public
data released. Unless otherwise noted, all non-
?nancial data for 2025 is drawn from the Company’s
headquarter. The Company assures that the content
of this report does not contain any false records,
misleading statements, or material omissions.
Important Notice
This report has been reviewed and approved by the
Company's board of directors for public disclosure.
The Company and the board assure that the content
of this report does not contain any false records,
misleading statements, or material omissions.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Basis for Compilation
Global Reporting Initiative The GRl Standards
Guidelines No. 14 of Shanghai Stock Exchange for Self-Regulation of Listed Companies--Sustainability
Report (Trial)
Guide No.13 for Self-Regulatory Supervision on Listed Companies of the SSE STAR Market-Compilation of
Sustainable Development Reports
United Nations "Guidelines for Corporate Action on the Sustainable Development Goals (UNSDGs)"
Access Information
The bilingual electronic version of the Report is available for downloading from the Eyebright Medical official
website (www.ebmedical.com/en) and the Shanghai Stock Exchange website (www.sse.com.cn).
For any enquiry or suggestions regarding the Report, please contact us via: investors@ebmedical.com or
(86)10-89748322. In case of any discrepancy or inconsistency in the versions, the Chinese version shall prevail.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Statement of the Board of Directors
The board of directors of Eyebright Medical assume overall responsibility for the accuracy, completeness,
and timeliness of the content and information disclosed in this report. As the core decision-making body of
corporate governance, the Board is fully and deeply responsible for matters related to Environmental (E), Social
(S), and Governance (G).
In the formulation of the ESG governance strategy, the Board has opportunities, the Board employs a rigorous
and professional approach, helping identify risks early and seize opportunities, ensuring a solid foundation for
the Company's stable development.
The board has established a comprehensive oversight mechanism, closely monitoring the progress of various
ESG initiatives to ensure that strategic decisions can be effectively implemented. At the same time, the board
continuously tracks the progress of ESG-related goals and adjusts strategies and action plans in a timely manner
based on actual conditions, ensuring that the Company continues to make positive progress in the ESG ?eld.
The board places great importance on information disclosure. Each year, the board conducts a rigorous review
of the Company's ESG report to ensure that the report accurately and truthfully reflects the effectiveness and
reliability of the Company's ESG e?orts.
This Report provides a detailed disclosure of Eyebright Medical's progress and achievements in ESG work in
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
With Light in the Heart, Progress
Moves Steadily Forward
—— Message from the Chairman
Dear Shareholders, Partners, and Friends from all walks of life,
In 2025, policy shifts and market headwinds led to the Company's first net profit decline. Guided by the Board,
we maintained strategic focus by prioritizing innovation, efficiency, and product optimization to navigate these
cycles. We remain confident that long-term value is grounded in technological barriers, continuous iteration,
and sustained responsibility.
Over the past year, we advanced our three core segments. Surgical treatment scaled core products such
as Prosert Intraocular Lens and The Loong CrystalTM PR Phakic Intraocular Lens, achieving steady market
expansion. Myopia management had a steady growth. The AI smart fitting platform improved clinical efficiency,
while R&D for new products maintained our leading edge. In myopia control, the “Healthcare + Consumer”
strategy drove expansion and improvements via the launch of silicone hydrogel lenses, functional lenses, and
care solutions.
The Company pursued synergistic growth through the acquisition of Delta Medical, entering the sports medicine
sector, and strategic overseas M&A via our Hong Kong subsidiary to establish a European foothold. As an
ophthalmic tech leader, we fulfill our social responsibilities through our core business, while deeply integrating
ESG principles—including compliance, talent empowerment, and green practices—into our core operations.
Looking ahead to 2026, the Company will focus on high-end innovation, deepen M&A integration, and advance
global deployment, steadfastly protecting nationwide eye health with greater resolve and concrete action.
With light in the heart, there is no fear of darkness. With steady progress and long-term vision, we will ultimately
reach faraway goals.
Eyebright Medical Technology (Beijing) Co., Ltd.
April 2026
Xie Jiangbing
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Performance Highlight in 2025
Business Highlight Innovation Empowerment
Operating Revenue RMB 1,482.70 Million Research and Development Personnel 289
Y-O-Y Growth 5.15% R&D Investment RMB 156 Million
Net Income Attributable to Shareholders RMB 268.17 Patents Applied 61
Million | Y-O-Y Growth -30.96% Patents Granted 41
Total Assets RMB 3,887.87 Million Total Patents Applied 480
Equity Attributable to Shareholders RMB 2,788.73 Total Authorized and Valid Patents 291
Million Participation in Standard Formulation and Industry
Basic Earnings per Share RMB 1.40 Report Compilation 9
Weighted Average Return on Equity 10.15%
Environmental Highlight Product Quality
ISO 14001 EMS Certifition External Audits Conducted 19 times
ISO 50001 EnMS Certifition National Supervision Pass Rate 100%
The Headquarter recognized as a "Beijing Green
Factory"
Conducted inaugural GHG inventory
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Employee Development Governance Performace
Total Employees 2,331 Total Board and Committee Meetings Held 16
Percentage of Female Employees 61% Disclosed Regular Reports 4
Percentage of Female Executives 50% Interim Announcements 52
Cash Paid to Employees RMB 383 Million Three Consecutive Years of Information Disclosure
Y-O-Y Growth 13.21% Rating Grade A
Training Sessions Conducted 224 Earning Calls Brie?ngs Held 6
Total Training Duration 17,536 Hours No Insider Trading
Total Number of Participants in Training 5,269 No Correction Announcements
Employees with Equity Incentives 77
Total Incentivized Shares 265,032 Shares
Community contribution and Social Recognition
Domestic Tax Paid RMB 159.20 Million
Hosted or Participated in Science Popularization and Charity Activities 17
Total Honors Received Throughout the Year 40+ Honors
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
About Eyebright Medical
Eyebright Medical Technology (Beijing) Co., Ltd. is a national high-tech enterprise and a national-
level specialized and innovative "little giant" enterprise founded by Dr. Xie Jiangbing. The
Group's headquarter is in the Zhongguancun Science Park in Beijing, with subsidiaries
established in Shanghai, Suzhou, Lianyungang, Yantai, Hong Kong and Switzerland. After
ten years of high-quality innovative development, the Company was listed on the STAR
Market of the Shanghai Stock Exchange in 2020, with the stock name "Eyebright
Medical" and stock code: 688050.
The Company's balanced product portfolio spans three major areas of the
ophthalmic field: cataract surgery, myopia management, as well as consumer
vision care. Adhering to its ?ve proprietary technology platforms, balanced
product portfolio, the Company has established a competitive advantage and
entry barriers in China, striding into a world-leading medical enterprise on behalf
of China's "intelligent manufacturing" power.
Business Layout
Surgical Treatment
The Company has developed and produced several domestic
pioneering and market-leading intraocular lenses, including over
(EDF).In 2025, The Company has launched China's first aspheric phakic
intraocular lens products, the Loong CrystalTM PR.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Myopia Management
As a technological pioneer in myopia management, the
Company launched the world's first full-arc aspheric
orthokeratology lenses. Other myopia management
products include defocus glasses, daily wear rigid
contact lenses, defocus soft lenses, and related
care products.
Consumer Vision Care
As a core player in consumer vision care，the Company
possesses proprietary technologies for contact lenses and
has established an integrated industrial layout spanning
R&D, manufacturing, and sales. Leveraging strengths, We are
developing premium lenses with enhanced comfort, safety,
and functionality.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Company Culture
Vision Illuminate Your World
Provide world-class ophthalmic technologies,
Mission
products and services
Innovative and Enterprising
Openness and harmony
Core Values
Honesty
Sharing Success
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Development Strategy
Eyebright Medical is dedicated to providing cutting-edge ophthalmic technologies, products, and services to
ophthalmic patients and vision care consumers worldwide. The Company will continue to implement a dual-
driven strategy of "Healthcare+ Consumer" alongside international development, continually extending its
product portfolio to provide comprehensive ophthalmic care solutions worldwide.
Unlock the potential of existing products to
solidify market leadership
Expand the consumer market and Boost R&D strength and speed up
explore new channels product tech innovation
Grow externally via M&A and Enhance overseas presence
partnerships to fuel growth
Case Case
In 2025, China’s first aspherical phakic intraocular The Company’s 24-hour smart contact lens stores
lens and Proming Extended Depth of Focus are included into the “2025 Key Application
Intraocular Lens were approved for market launch Scenario Support Project List” list and the
via the NMPA. Additionally, the Company’s self- commercial deployments of embodied AI
developed high-Dk silicone hydrogel contact lens are being recognized . Powered by Galaxy’s
received regulatory registration. humanoid robots, stores are now open in
major cities across China, offering a testbed for
Case embodied AI and ready to expand nationwide.
Driven by the growth strategy, the Company
acquire a controlling stake in Delta Medical, Case
an international sports medicine company In 2025, the Company boosted its global presence
covering the full care cycle from prevention by showcasing ophthalmic products across three
to rehabilitation. This move leverages Delta’s key sectors at major international forums and
integrated capabilities in implants, instruments, industry exhibitions. Through in-depth exchanges
and equipment to extend the Company’s R&D on cutting-edge technologies and trends with
and management strengths into the high- global stakeholders, the Company significantly
potential medicine sector, creating new profit enhanced its international influence.
drivers and securing long-term growth.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Development History
Expanding Product Portfolio and
Rapid Commercialization
Toric IOL
Early Technology Accumulation Domestic Users are Covered by Over
Proming A1-UV, the First Domestically-
Manufactured IOL with Independent
Intellectual Property Rights
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Market
Proming Continuous Vision Received NMPA Approval
Established Eyebright Hong Kong advance Internationalization Strategy
Beijing Future Science City Marketing Center in Operation
Strategic Cooperation with Meituan Medicine to Launch 24-hour Smart Stores for Contact Lens
Lens has received NMPA Approval
Proming Extended Depth of Focus intraocular lens Received NMPA Approval
Self-developed High-Dk Silicone Hydrogel Contact Lens Received NMPA Approval
Established Eyebright Switzerland
Acquired OphthalmoPro GmbH
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Awards and Recognitions
Beijing Headquater
Beijing Top 100 Private Enterprises China Listed Company Tianma Award - Investor
Relations Management Innovation Practice Award
Global Ophthalmic International Cooperation Award
Cutting-edge Enterprises The 16th China Listed Company Investor Relations
Pegasus Award
Value Demonstration Case
Excellent Private Science and Technology Enterprise
Beijing Intellectual Property Advantageous Unit
Case
Top 500 New Economy Enterprises
Top 30 STAR Market Listed Companies
Listed Company 2024 Annual Report Performance
Briefing Best Practice Case
SSE Eagle · Golden Quality Award – Sustainable
Growth
Securities Daily · Golden Steed Award- Most Valuable Beijing Changping District 2024 Excellent Science
Investment Listed Company Popularization Base
Securities Daily · Golden Junma Award - Listed Beijing Changping District “Rule of Law Assisting
Companies with the Most Investment Value Enterprises · Dual Exemption Whitelist” Category I
Enterprise
爱博诺德（?京）医疗科技股份有限公司：
荣获2025?上市公司董事会办公室优秀实践，
特发此证。
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Holding Subsidiaries
Fujian "Gazelle" Innovative Enterprise in the Core Industry of Digital Economy
Jiangsu Gazelle Enterprise
Taobao Flash Buy Medicine Annual Growth Brand, New Retail Pioneer Award
Advanced Unit in Optometry and Ophthalmology
Products Awards
Beijing 2025 First Batch Catalog of Major Technical Equipment
The 19th Beijing Invention and Innovation Competition Gold Award
Certificate of Scientific and Technological Achievement
Beijing New Technology and New Product
Sustainability Awards
Gold Seal of the Pilot Program for Climate-related Financial Disclosures
Wind ESG Rating Level A
证 书 綠?和可持續
貢獻
爱博诺德 ( 北京 ) 医疗科技股份有限公司入选
中 国 上 市 公 司 协 会 2025 年 上 市 公 司 可 持 续 发 展 优
秀实践案例。
特发此证，以资鼓励！
可持續相關財務信息披露
先導計劃?章
中国上市公司协会
二零二五年十一月
愛博諾德 (香港) 醫療科技有限公司
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Sustainability Management
Eyebright Medical has continued to advance human vision health with a commitment to aligning social
responsibility with sustainable corporate development. As a responsible corporate citizen, the Company works
steadily to fulfill its mission. Based on our actual capabilities and seize opportunities arising from the changing
environment in the new era. The Company further strengthen our initiatives in Environmental, Social and
Governance (ESG) and proactively respond to the concerns and expectations of both internal and external
stakeholders.
United Nations Sustainable Development Goals
ESG Strategic Planning
The Company continuously optimize the governance framework, identify
and assess key risks, and develop measures to establish a standardized,
transparent, and fair governance mechanism that ensures sustainable
Operational Sustainability development.
R&D innovation drives our sustainable growth. The Company will increase
investment to develop cutting-edge ophthalmic technologies and
products.
Product Sustainability
The Company prioritize employee rights by fostering a diverse, inclusive,
and equitable work environment. The Company will remain actively
involved in social welfare activities, leveraging our expertise to contribute
Social Sustainability greater value to society.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
ESG Management System
To enhance ESG management practices, Eyebright Medical has established a multi-tiered management
system. The board, as the supreme decision-making body, oversees ESG strategy and disclosure annually.
Senior Management integrates ESG principles into all business processes, while a dedicated ESG Task Force
spearheads action plans for key initiatives. Meanwhile, designated liaisons across functions and subsidiaries
ensure efficient data collection and report compilation. This systematic mechanism aligns ESG goals with
business growth, ensuring effective implementation organization-wide.
Directors Oversees ESG strategy
Senior Management Integrates ESG principles
ESG Task Force Spearheads action plans
Data collection
Designated Liaisons
Report compilation
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Stakeholder Communication
Stakeholders Expectations and Demands Response Methods/Communication Channels
Enhance corporate governance and investor relations
•Regulated Corporate Governance
involves, and use online platforms to promptly
Shareholders •Sustained Value Creation
address investor inquiries. Deliver consistent
•Information Disclosure
pro?tability and timely ?nancial disclosures
•Product Safety and Quality
Provide high-quality products and services,
•Diverse O?erings
Customers implement robust information security measures to
•Privacy and Information Security
ensure the protection of customer privacy
•Responsible Marketing
•Basic Rights Protection Sign labor contracts and remits social insurance
•Training and Promotion in compliance with local law. Maintain competitive
Employees •Compensation and Bene?ts salary levels, provide multidimensional trainings for
•Health and Safety employees. Maintain rigorous occupational health
•Work-Life Balance and safety standard
Establish mid-to long-term environmental
•Environmental Protection
management goals, implement energy-saving and
•Reduce Pollution Emissions
Environmental emission-reduction initiatives, and promotes green
Groups •Enhance Energy Efffciency
offfce practices
Establish standardized procurement systems and
enhances supply chain management, maintain a
•Win-Win Cooperation
fair and orderly competitive environment. Build
Partners •Sustainable Supply Chain
academic exchange platforms and conducts industry
•Contribute to Industry Development
training, initiates industry-university-research
cooperation projects
Government •Operate in accordance with the law Ful?lls tax obligations, enhance anti-bribery and
and Regulatory
Authorities •Comply with business ethics anti-corruption measures
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Materiality Assessment
Conducting a materiality assessment is fundamental to the Company.during the Reporting Period, the Company
employed surveys and internal workshops to evaluate issues based on two dimensions: financial materiality
(impact on the Company) and impact materiality (effect on the economy, environment, and society). The
assessment results have been systematically integrated into our enterprise risk management framework, with
key stakeholder priorities disclosed in this Sustainability Report. The specific methodology is as follows:
Step 1 Step 2 Step 3 Step 4
Understand
Corporate Materiality and
Establish the Identify
Activities Sustainability
Issue List Material Issues
and Business Disclosure
Context
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Environmental
Eyebright Medical incorporates green development into its business
strategy and operations. By enhancing environmental awareness,
optimizing resource use, minimizing waste, and adopting sustainable
practices, the Company proactively assumes environmental
responsibilities, fostering harmonious coexistence between humans
and nature.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Environmental Management
Eyebright Medical diligently fulfills its environmental responsibilities, enhances its management systems, and
implements eco-friendly practices. The Company promotes renewable energy and sustainable development,
striving for a mutually beneficial relationship between economic performance and environmental protection.
Environmental Management System
The Company strictly complies with the Environmental
Protection Law of PRC and integrates environmental
management throughout its operations. In 2025, it
enhanced its environmental management system by
optimizing processes and upgrading facilities, significantly
improving governance effectiveness. In March 2025, the
Company obtained ISO 14001 certification, signifying
a new level of standardization in its environmental
management practices.
Compliance Management and Audit Oversight
The Company implements the environmental impact assessment system to ensure approvals and
completion of EIA and environmental acceptance inspections. It conducts regular self-inspections and
audits to guarantee environmental compliance.
Organizational Structure and Goal Management
The Company has established a robust environmental management framework with designated focal
points. Detailed EHS goals are decomposed to specific roles, linked to performance appraisals, and
managed through a closed-loop system.
System Development and Certification
The Company optimizes its environmental management processes and has achieved ISO 14001 and ISO
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Key Initiatives for Green Transition
During the Reporting Period, the Company's headquarter was recognized as a "Beijing Green Factory"
by the Government.
Multiple clean production improvement plans were systematically implemented, enhancing resource
utilization efficiency.
Environmental Investments
During the Reporting Period
dedicated environmental funds were allocated primarily for:
Upgrade waste gas treatment facilities Tech Upgrades for Energy Saving & Carbon
Reduction
Investments in clean production Delivery of environmental training and
awareness campaigns
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Environmental Risk Management
The Company enhances its environmental risk management capabilities, adhering to the principle of “Prevention
First, Integrated Control, and Comprehensive Oversight.” It complies with the Environmental Protection Law
of PRC and has established a lifecycle environmental risk management system, significantly bolstering its risk
prevention and control abilities.
Systems and Process Assurance
The Company has formulated 10+ specialized regulations to clarify environmental risk control responsibilities
across departments and positions, ensuring compliance at all levels.
Routine Compliance Audits
Regular self-assessments and audits are conducted, focusing on pollutant emissions, the operation of
environmental facilities, compliance with EIA and the "Three Simultaneities" system, emergency response plan.
Issue trackers are established to manage identified problems.
Comprehensive Risk Prevention Measures
The Company identifies lifecycle environmental risks, categorizing and controlling risks in production processes
and equipment operation. Preventive measures are implemented, supported by process optimization and
upgrades to environmental facilities. Key control measures include:
Risk Type Control Initiative Result
Installed fume hoods at key positions Emissions exceed the "Integrated
Air Pollution Risk and closed collection systems for VOCs; Emission Standard of Air Pollutants"; full
equipped with exhaust treatment. compliance of fugitive emissions.
Added soundproof enclosures for high- Bound ar y noi se l eve l s c omp l y wi th
Noise Pollution
noise machinery; used sound-absorbing standards, safeguarding employee and
Risk
materials and optimized layout. community health.
Established an integrated wastewater
Water Pollution Wastewater complies with the "Integrated
treatment system, discharging into
Risk Discharge Standard of Water Pollutants".
municipal sewage.
Created a regulated solid waste storage
Solid waste disposal adheres to legal
Solid Waste area; managed hazardous waste with
requirements; no risks of illegal dumping
Pollution Risk proper labeling, transfer records and
or leakage.
disposal by qualified organizations.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Emergency Response Capacity Building
Emergency Response Plan System
The Company revised its "Emergency Response Plan for Environmental Incidents", outlining procedures
and responsibilities for emergencies like gas leaks and wastewater exceedances. The plan is registered with
environmental authorities and updated dynamically.
Practical Emergency Drills
In 2025, the Company organized emergency drills focusing
on key environmental risk scenarios.
During the Reporting Period
No environmental violations occurred
No media exposures were recorded
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Pollution Prevention
Eyebright Medical prioritizes environmental protection and is not classified as a heavy polluter. The Company
complies with the laws and regulations, integrating pollution prevention into all operations. It reduces emissions
through environmental equipment installation and process improvements.
Qualified third-party organizations monitor During the Reporting Period
wastewater, exhaust, and noise levels to ensure
compliance with local standards, with all tests results No major pollution incidents occurred
during the Reporting Period met requirements. within the Company or its subsidiaries
Wastewater Management
The Company adheres to national and local During the Reporting Period
standards, establishing a comprehensive wastewater
management system that ensures effective All treated wastewater indicators met national
and local discharge standards
environmental accountability through categorized
collection, differentiated treatment, and compliant No discharge exceedances or related
environmental complaints occurred
discharge.
Facilities and Pipeline Treatment Processes Rainwater Management
Wastewater treatment Treated production
facilities and standardized wastewater and filtered A rainwater retention
discharge points are kitchen sewage flow system collects rainwater
established, with a separate into septic tanks before for irrigation, promoting
drainage system to prevent being discharged into the resource reuse.
cross-contamination. municipal sewer network.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Waste Gas Management
The Company adheres to the "Integrated Emission Standard of Air Pollutants" and ISO 14001 requirements,
establishing a gas management system that includes source control, categorized collection, targeted treatment,
and compliance monitoring to minimize atmospheric impact.
To ensure compliance, it employs various purification methods, such as activated carbon adsorption and
advanced grease traps. Regular emissions monitoring conducted by professional organizations during the
Reporting Period consistently met compliance standards.
Case
VOCs and Exhaust Treatment
The Company has upgraded specific production
zones by implementing workshop enclosure and
installing fume hoods at operational points. This
initiative has significantly reduced unorganized
fugitive emissions. Process exhaust from
production and exhaust generated during R&D
activities are collected via dedicated ductwork During the Reporting Period
and directed to specialized treatment units
for purification, ensuring that final emissions
All exhaust indicators met compliance
requirements
comply with national air pollutant discharge
standards.
No emission exceedances or related
complaints recorded
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Waste Management
The Company complies with the Law of PRC on the Case
Prevention and Control of Environmental Pollution by
Solid Wastes and the Regulations on the Administration
In 2025, the Company continued to
of Medical Wastes, establishing a comprehensive
focus on hazardous waste control by
waste management system that includes categorized
strengthening management measures
collection, proper storage, compliant disposal, and
to reduce ethanol consumption,
source reduction to control environmental risks.
minimizing hazardous waste generation
General solid waste includes material preparation at the source, and steadily advancing
scraps, waste packaging materials, and domestic waste the implementation of waste reduction
that do not fall under the category of hazardous waste, targets.
is managed by qualified third-party organizations.
Hazardous waste, including experimental liquids
and reagent bottles, is strictly controlled and stored
separately in specialized containers, with harmless
disposal conducted by qualified third-party entities.
Regular training on hazardous waste management laws
and disposal procedures ensures comprehensive control
at all stages.
Case
Since 2024, HiGenie has run an "Empty Tube
Recycling" program for its single-use ampoules,
encouraging consumers to participate in
environmental protection through incentives
like shopping credits and skincare products,
thereby promoting the concept of sustainable
development.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Noise Management
The Company complies with the Emission Standards for Industrial Enterprises Noise at Boundary and ISO 14001
requirements, ensuring that boundary noise levels meet regulatory standards to minimize noise pollution and
protect health. Furthermore, the Company optimally designs facility layouts and strategically plans production
processes to effectively control noise generation at the source.
Noise Reduction Measures
Fans and Air Compressors
install professional silencers to reduce operational noise
Pumps and Fluid Transport Equipment
Install soundproof walls and doors to minimize noise propagation
Production Equipment
Soundproof enclosures are employed to contain equipment noise and prevent its propagation
Advanced sound-absorbing materials and scientific techniques are applied to the operation room
to reduce overall noise levels
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Resource Management
Eyebright Medical has strengthened its normalized resource governance, strictly applying the principles of
reduction, reuse, and resource recovery at the operational level. By comprehensively enhancing resource
efficiency, the Company leverages its innovative strengths to accelerate the implementation of circular economy
models and green substitution strategies.
Water Resources Management
The Company prioritizes the environmental impact of water consumption and actively focuses on conservation
and efficient use. Regular monitoring is conducted for the identification of anomalies, enabling prompt analysis
and targeted measures.
Water-Saving Measures
Optimize landscape water usage based on actual demand
Install water-efficient faucets with optimized flow rates to
ensure rapid flushing and effective cleaning
Display water conservation signage to raise employee
awareness and encourage responsible usage
Establish quarterly water consumption targets, regularly
monitor and review usage data, and promptly formulate water-
saving plans
Energy Management
The Company actively promotes the systematic development of its energy management framework and has
formulated institutional documents such as the Regulations on Energy and Energy Conservation Management.
By driving diverse energy-saving initiatives, the Company continuously explores potential for reducing
consumption, effectively curbs energy use, and enhances efficiency, thereby fostering a sustainable operational
model centered on energy conservation and efficiency gains. In February 2025, the Company successfully
obtained ISO 50001 Energy Management System certification.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Energy-Saving Measures
HVAC Efficiency
Implement variable frequency drives and energy-efficient designs
Lighting Control
Use timed lighting for indoor areas and automatic controls for outdoor lighting based on natural light
Smart Power Management
Establish an intelligent power management system for precise electricity control
Case
Eyebright Yantai Compressor Waste Heat Recovery Project
This project recovers waste heat from
compressor circulating water. By
industrial heat pumps, the return water
temperature is raised to hot water
boiler standards, integrating heated
water into the supply system. This
effectively reduces boiler startup loads
and lowers gas consumption.
Since its launch, over 15 TJ of heat has
been recovered and utilized.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Green Production
Eyebright Medical employs advanced environmental technologies and equipment in its manufacturing
processes, focusing on clean production principles of reduction, reuse, and recycling. The Company continually
reduces energy consumption, water usage, and pollutant emissions, fostering harmony between the medical
industry and the environment.
Case
Optimized Process Operations
Enhanced drying processes to reduce solid waste and achieve cost savings
Automated Visual Verification
Developed automated systems for accurate information assessment, improving verification
efficiency
Automated Packaging Line
Implemented upgrades to minimize waste generation during production
Automated Record Keeping
Automatically record testing data and generate electronic documents, enhancing efficiency and
reducing paper use
Scanning Inventory System
Generate unique device identifiers (UDI) to improve inventory management and traceability
PDA Distribution System
Automate product scanning for outbound logistics, reducing errors and enabling automatic record
archiving
Classified Recycling
Enforce "Categorized Collection, Dedicated Management, and Compliant Disposal" for hazardous
waste, ensuring 100% disposal rates
Optimized Filter Consumables
Strengthen front-end dust control to reduce the load on primary and medium-efficiency filters,
thereby decreasing filter replacement frequency and consumption
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Green Office Practices
Eyebright Medical promotes green office practices and eco-friendly commuting through digital, paperless
operations to reduce resource waste and energy consumption. The Company fosters energy conservation
awareness and a low-carbon culture in daily operations.
Office Supplies Management Electricity Management
Implement energy-efficient lighting and on-
Promote paperless operations demand controls
Control printed materials Regulate air conditioning to minimize energy use
Procure office supplies responsibly Establish an energy inspection system to
eliminate waste
New Energy Vehicle Adoption Green Environment
Gradually replace company vehicles with new
energy vehicles Use low formaldehyde materials in office
Encourage green commuting by providing public renovations to meet clean standards required
transport support for employees for the medical device industry
Climate Action
The Company recognizes the importance of proactive management in addressing physical and transition
risks from global climate change. During the Reporting Period, the Company identified and assessed climate-
related risks and opportunities, initiated climate resilience planning, and developed low-carbon transformation
pathways aligned with its carbon neutrality goals.
The Board has incorporated climate change into long-term strategic planning as a key governance issue,
defining our commitment to green development. The management team is implementing critical initiatives
such as energy management system certification, low-carbon technology innovation in R&D, and production
upgrades. The Company has also established emergency response plans and risk management mechanisms to
enhance its climate governance framework and improve its capacity to manage environmental risks.
Climate-Related Risks
This qualitative climate risk analysis is founded on the climate scenarios published by NGFS. To comprehensively
evaluate risks, the Company selected the "NDC Scenario" within the "Hot House World" as high-emission, and
the "Below 2 ℃ Scenario" within the "Orderly Transition" as low-emission. The assessment identifies flood risks
caused by heavy rainfall and typhoons as the primary physical risks currently facing the Company. Based on the
analysis, the Company has formulated corresponding risk mitigation measures. The Company will fully consider
risk evolution trends under these climate scenarios, and strengthen safeguard measures to ensure climate-
related impacts.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Potential
Potential Risk Mitigation
Risk Classification Risk Characteristics Operational
Financial Impact Measures
Impact
Establish
Extreme weather
emergency
events threaten
response plans
supply chain
for environmental
stability, impacting Increased energy
incidents; enhance
product availability costs, operational
disaster resilience
Extreme weather risks Coastal facilities disruptions,
Acute of production
(short to medium term) in Fujian Province higher safety stock
facilities; properly
and other regions requirements, profit
allocate commercial
are most severely margin pressure
insurance to
impacted by
Physical Risks mitigate economic
typhoons and heavy
losses from extreme
rainfall
weather
Identify high-risk
Increased
Sea-level rise assets; implement
adaptation
Sea-level rise increases flooding national flood
Chronic expenditures; asset
(irreversible risk) risks in coastal design standards
impairment risk if
areas in engineering
flooding occurs
projects
Increased Closely monitor
production costs, changes in
Strengthened including capital international
Enhanced Energy energy efficiency expenditures and domestic
Efficiency and Carbon and carbon for energy- environmental
Emission Assessments emission saving upgrades and low-carbon
(Short to Medium Term) assessments under and equipment regulations; comply
peak carbon policies renewal; short-term with requirements
operational cost to mitigate legal
rises risks
Policy and
Regulation
Inclusion in
mandatory
emissions
Transition Risks
Inclusion in Mandatory trading schemes Increased Install distributed
Carbon Emissions necessitates carbon costs and PV systems to boost
Trading Market (Short to compliance with management self-sufficiency in
Medium Term) quotas, emission expenses green power
oversight and
disclosure
obligations
Continuously track
Enhanced green Insufficient green
market trends
Enhanced green procurement credentials may
and customer
procurement preferences may hinder market
Market demands; adjust
preferences (medium to raise focus on low- access, adversely
business models
long term) carbon attributes in affecting revenue
and strategies
bidding evaluations and market share
accordingly
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Rising consumer
Poor management of
Rising consumer awareness of
brand environmental Implement green
low-carbon
awareness of low- footprints may hinder actions; enhance
impacts increases
carbon impacts sales growth and green brand
scrutiny on brand
erode brand premium communication
(medium term) environmental
potential
responsibility
The production
process must
enhance energy
Pressure to enhance Increased capital Promote green
efficiency through
energy efficiency expenditures due to production principles;
upgrades, energy
and upgrade equipment upgrades optimize processes;
substitution,
production systems and technological bolster R&D in low-
or process
(Medium term) modifications carbon technologies
optimization to
meet low-carbon
emission standards
Continuous
Technology
development
of low-carbon Increase R&D
Continuous
processes and investment in low-
development
alternative carbon technologies;
of low-carbon Rising R&D expenses;
materials may lagging technology explore new
processes and
necessitate updates could affect alternative materials
alternative long-term cost control
upgrades in to reduce reliance
materials (long
production tech; on traditional high-
term)
inadequate reserves carbon inputs
may lead to
adaptation delays
Incomplete Improve climate
Insufficient climate or inaccurate information
Stock price volatility;
disclosure or disclosures could disclosure; engage
potential brand
data accuracy trigger regulatory damage affecting third-party
Reputation
concerns may raise scrutiny or media long- to medium-term verification for
sales and market
"greenwashing" reports, damaging key carbon data;
valuation
allegations investor trust and proactively address
market perception stakeholder concerns
Climate Resilience and Adaptation
In response to escalating physical risks, the Company actively monitors industry trends, regulatory
developments, and expert risk forecasts to anticipate climate threats. By enhancing local adaptation capabilities
and optimizing emergency protocols, the Company can mitigate potential business interruptions and financial
losses.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
The Company has identified key risk points and implemented targeted
management. The Safety and Environment Department has developed emergency
Emergency plans for extreme weather and conducts regular drills to ensure quick response,
Response protect employees and assets, and restore operations promptly. Major production
sites use dual power supply to maintain stable power for key equipment during
maintenance or emergencies.
The Company manages supply chain risks by maintaining safety stock and
Supply Chain using multiple suppliers to avoid over-reliance. The Company only works with
Resilience suppliers that meet environmental standards, which the Company verifies
through on-site checks.
Climate resilience is embedded into our capital investment framework.
Investment During the feasibility stage for new or expanded projects, the Company
Decision-Making assesses historical climate data to optimize site selection, design standards,
and construction specifications, ensuring long-term business sustainability.
To address policy, market, and technology-related transition risks, the Company implements the following
strategies:
Energy and Carbon Management Operational Optimization
Through robust energy management systems The Company promotes green practices across
and efficiency upgrades, the Company reduces offices and production sites to lower resource
fossil fuel dependence to minimize future consumption and emissions, aligning with
compliance costs associated with carbon increasingly stringent regulatory requirements.
pricing and taxation.
Low-Carbon R&D Environmental Management System
The Company innovation process integrates The Company continuously maintains ISO14001
energy efficiency, material recyclability, and certification to institutionalize environmental
lifecycle environmental impact assessments. governance, ensuring agile policy response and
This drives technological advancements that compliant operations.
mitigate transition risks and unlock new market
opportunities.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Greenhouse Gas Emissions
The Company conducted a comprehensive annual greenhouse gas inventory, adopting the operational
control approach in accordance with the General Guideline of the “Greenhouse Gas Emissions Accounting and
Reporting for Industrial Enterprises” (GB/T 32150) and the “Greenhouse Gas Protocol: Corporate Accounting
and Reporting Standard”.
This inventory established the Company’s emissions baseline, pinpointing core hotspots and decarbonization
levers. Building on this baseline, the Company has systematically quantified climate risks, set science-based
emission reduction targets, and formulated specific adaptation measures and transition roadmaps.
Greenhouse Gas Emissions Unit 2025
Scope 1 ktCO2e 2.68
Fossil Fuel Combustion ktCO2e 1.42
Direct Fugitive Emissions ktCO2e 1.26
Scope 2 ktCO2e 28.74
Electricity ktCO2e 27.78
Heat ktCO2e 0.96
Total Emissions (Scope 1 + Scope 2) ktCO2e 31.42
Notes：
mobile source combustion (Gasoline, Diesel), refrigerant fugitive emissions, and wastewater treatment.
Emission factors for fossil fuels reference the IPCC Guidelines for National Greenhouse Gas Inventories and
China National Greenhouse Gas Emission Factor Database; methane factors for industrial wastewater reference
the latter.
factor references the “2023 National Average CO2 Emission Factor for Electricity” issued by China’s Ministry of
Ecology and Environment.
Ecosystem and Biodiversity Protection
Eyebright Medical adheres to environmental protection laws, including the “Forest Law of PRC and Law of PRC
on Water and Soil Conservation”. The Company uses resilient, low-maintenance plants to create diverse green
landscapes that improve local microclimates and protect biodiversity. A rainwater collection system further
reduces runoff pollution and provides recycled water for irrigation.
Through these ecological initiatives, the Company fosters a sustainable ecosystem that enhances ecological
value and creates a quality green workspace for employees.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Social
Eyebright Medical actively fulfills its corporate social responsibility
by prioritizing research and innovation, promoting academic
exchange, and ensuring stringent product quality while optimizing
the supply chain for sustainable value chain development. The
Company values employee growth and is committed to providing
a robust career development platform. Additionally, it actively
participates in social welfare activities, leveraging its resources and
capabilities to enhance public health and contribute positively to
society.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Innovation-Driven
Eyebright Medical prioritizes innovation as the cornerstone of high-quality development. In ophthalmology
medicine, it accelerates research and development (R&D) initiatives, strengthens its talent pool, and creates
a comprehensive industry-university-research platform, thereby establishing a solid mechanism to support
scientific innovation.
Scientific Research Framework
The Company has refined its R&D management To enhance R&D efficiency and quality, Eyebright
policies and improved its innovation capacity. Medical builds a high-caliber research team
The Company utilizes a project leader system through a regular training regimen that focuses on
wherein the leader oversees the entire product advanced knowledge, standardized procedures,
development process, from initiation to post-market and compliance with industry regulations, thus
feedback. This structure enhances collaboration ensuring effective project execution and quality
and increases product development success rates. control.
Company R&D Workflow
Market Preliminary R&D Project
Research Experiments Initiation
Eyebright Medical R&D Annual Meeting 2025
Clinical Trials Type Product
Inspection Development
and Finalization
Product Market Post-Market
Registration Launch Clinical
Research
Session II of Patent Training
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
R&D Investment
Million (RMB)
Technical innovation is vital for maintaining 159.82 156.32
Eyebright Medical's core competitiveness.
The Company emphasizes cutting-edge 132.30
technology and consistently allocates a
significant portion of its resources to R&D,
thereby enhancing innovation and efficiency 2023 2024 2025
to support its strategic objectives. Accumulated R&D investment reached RMB
（As of December 31, 2025）
Recently Introduced Products
China
Non-Refractive Rigid
Proming Extended Gas Permeable Contact
The First Aspherical Phakic Intraocular Lens Depth of Focus Lens for Orthokeratology
in China, The Loong CrystalTM intraocular lens (NORW)
Upgraded Designs for 7 models of Soft
Contact Lens Care iBright AI Digital Multiple Defocus Frame Hydrophilic Contact
Solutions Fitting System Glasses Lenses
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Overseas
Monofocal and Extended Depth of Focus intraocular lenses received MDR CE technical
assessment certificates
Multiple preloaded intraocular lens products gained regulatory approval in Malaysia, Vietnam,
Peru, and other countries along the Belt and Road
Successfully completed on-site quality system audits by regulatory authorities in Korea and
other regions
Obtained listing certificates from the Hong Kong Department of Health’s Medical Device Division
for various products, including the phakic intraocular lens, a full range of intraocular lenses, and
orthokeratology lenses
Intellectual Property Protection
Eyebright Medical complies with national innovation strategies and relevant laws, such as the Patent Law
and Copyright Law of PRC. The Company has established robust mechanisms for patent and copyright
protection, implementing internal guidelines to promote the recognition and commercialization of patents,
thereby enhancing its intellectual property management capabilities.
During the
Reporting 61 41
Period Patents Applied Patents Granted
As of 480 291
December Total patents applied Total authorized and valid patents
International patents cover regions including Europe, the
United States, Japan, South Korea, and Singapore
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Experimental Ethics
The Company rigorously complies with welfare and ethical review standards in animal experiments.
Reduction Replacement Refinement
"3Rs" principle
All commissioned animal studies are conducted by certified third-party institutions that meet AAALAC
standards. Ethical governance is a key admission criterion, requiring the establishment of an Independent
Animal Care and Use Committee (IACUC) for mandatory review and oversight.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Collaborative Industry Advancement
Eyebright Medical actively fosters domestic and international academic exchanges, establishing a global
platform that integrates medical research with clinical practice. The Company participates in industry
standards development and collaborates with universities to cultivate ophthalmic talent, thereby advancing
innovation in ophthalmic care.
Academic Exchange
The Company recognizes collaboration as essential
for technological innovation and has engaged During the Reporting Period
in numerous academic activities to create a
comprehensive exchange platform. By organizing
and attending forums and seminars, it collaborates 2
with experts to explore cutting-edge technologies International Exhibitions
and address key academic challenges.
In 2025, Eyebright Medical participated in major 18
National Conferences
conferences, including Congress of Chinese
Ophthalmological Society (CCOS) and Vision China
events such as ESCRS and IOC, and gaining Regional Meetings
recognition for its advanced technologies.
Self-hosted Meetings
Online Participants
Online Total Views
Online Viewing Time
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Case
Clinical Application Sharing
of Bifocal Intraocular Lens
This regional academic exchange promotes bifocal
intraocular lens, engaging nearly 600 clinicians across
ophthalmic technology.
COE Center Launch
The Company established the "Cataract Surgery
Demonstration Center" in partnership with medical
institutions. This event involved nearly 100 professionals,
promoting standardized treatment for cataract.
Advanced Training Camp
for Refractive Multifocal Intraocular Lens
This online camp addresses complex cases like high
myopia, providing targeted training for KOLs in public and
private institutions to enhance product application skills.
Myopia Management Investigation Journey
Now in its fifth year, this event has attracted over 800
clinical practitioners, establishing itself as a brand-driven
academic benchmark.
The 2025 competition covers six major regions with 11
events, fostering a continuous platform for learning,
exchange, and growth through a "fixed team, annual
points, ultimate showdown" format.
Myopia Prevention
and Control Seminar with IAOA Training
Collaborating with IAOA, the Company hosted
foundational training that integrates theory and practice,
receiving high praise with eight sessions conducted in
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Case
Clinical Symposium
on iBright Defocus Frame Lens
The iBright series has garnered positive feedback
since its launch. Several clinical symposiums were
held to support effective myopia prevention in
children and adolescents.
Domestic Intraocular Phakic Lens
Application Summit
Following the launch of the Loong CrystalTM, whose
technology has broken the imported dominance. To
standardize the clinical application, the Company
organized multiple Summit Seminars for the
"Domestic Intraocular Lens Clinical Application"
throughout the year, covering around 200 surgeons.
Standard Establishment
High standards are crucial for driving quality development. Corporate standards underpin innovation,
technical capacity, production efficiency, and social responsibility, while facilitating communication and
trust among enterprises, clients, partners, and the public. Eyebright Medical actively participates in the
standardization of medical devices to promote high-quality industry development.
In 2025, the Company joined the ISO/TC172/SC7 International Organization for Standardization for
Ophthalmic Optics and Instruments, contributing to the drafting and revision of various national and
industry standards. These efforts cover areas such as intraocular lenses, frames, and corneal reshaping
lenses, reinforcing the advancement of the industry.
Standard Name Participation
T/CI 1363-2025 Code of Application for Spectacles in Myopia Management
Participation in Drafting
Related to Myopia Prevention and Control
GB 11417.2-2025 Ophthalmic Optics - Contact Lens - Part 2: Rigid Contact
In Revision and Validation
Lens
GB 11417.3-2025 Ophthalmic Optics - Contact Lens - Part 3: Soft Contact In Revision and Validation
Lens
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
School-Enterprise Cooperation
iBright Spark Program
Eyebright Medical's "iBright Spark Program " enhances R&D and talent cultivation through school-
enterprise collaboration. By sharing resources and developing joint curricula, it creates training bases that
integrate education with industry, improving talent quality and efficiency to meet market demands and
support industry growth.
During the
Reporting RMB 700,000 in materials 2,000+ students 188
Period Donated over Benefited Training Hours
Collaborated Extended Donated over
Since 2022
training hours 4,500+ students 15,000+ professionals
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Training & Empowerment
Three Major Training Centers for Orthokeratology Lense
Eyebright Medical collaborates with renowned To address the industry's demand for interdisciplinary
ophthalmic hospitals and industry associations talent, Eyebright Medical initiated the first
to establish three training bases in China Eye management empowerment class for optical centers
Valley, Tianjin Eye Hospital Optometric Center, in 2025 at Tianjin Eye Hospital's Optometric Center
and its Beijing headquarters. These bases offer teaching base. The class class employs a "Technology
a comprehensive learning platform for vision + Management" dual-core model, focusing on digital
care practitioners, focusing on standardized system development, customer management, and
fitting of orthokeratology lenses and myopia talent cultivation, thereby enhancing the skills and
prevention. operational management capabilities of participants.
During the
Reporting 3 80+ 110+
Period training sessions training hours attendees
Since 2021 30+ 400+ 650+
provinces and regions hospitals and optical centers industry professionals
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Cataract Phacoemulsification Training Center
Eyebright Medical established a cataract surgical
In 2025, it delivered 3 phacoemulsification
training platform for phacoemulsification,
training sessions, supported 40+ clinicians, and
providing year-round training for hospital
hosted 130+ physicians from 70+ hospitals-
doctors at major hospitals.
including participants from Belt and Road Initiative
countries-while providing equipment and venue
support for in-hospital training.
Loong CrystalTM PR Certification Training
At the beginning of 2025, the Loong CrystalTM PR Phakic Intraocular lens, the
nation's first aspheric phakic intraocular lens, was launched. To effectively
standardize the clinical application and market promotion of this product,
Eyebright Medical implemented extensive and systematic training.
Conducting 11 doctor certification training sessions throughout the year.
Holding 360+ clinical department training meetings.
IBRIGHTELITE Youth Paper Award
Founded in 2021, the IBRIGHTELITE Youth Paper
Award, in collaboration with Vision China, encourages
young ophthalmologists, vision care practitioners, and
students to explore the fields of ophthalmology and
visual health. It promotes academic exchange and
innovation, fostering the growth of future leaders in the
eye care industry.
Premier Paper Award Excellence Paper Award Outstanding Paper Award
During the
(Best Winner)
Reporting
Period
Popular Paper Award Excellent Poster Award Supported
Since 2021 334
Total Young Scholars Funded
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Accessibility of Medical Services
Eyebright Medical emphasizes value creation, striving to offer high-quality, accessible eye health services.
The Company integrates intelligent solutions, including artificial intelligence, to enhance the quality and
availability of ophthalmic care, ensuring equitable and efficient services for underserved populations.
Promotion of 24-Hour Smart Contact Lens Stores
Eyebright Medical's 24-hour smart contact lens store project has
been recognized in the "2025 Key Application Scenario Support
Project List" for its innovative use of embodied intelligence.
Successfully launched in cities like Beijing, Shanghai, Guangzhou,
Shenzhen, Chongqing, and Hangzhou, these stores utilize humanoid
robots to enhance customer service. The Company is committed to
expanding this initiative nationwide.
Eyebright Medical Eye Health Education Center continues to run Professional Program
Eyebright Medical addresses key public health
issues, including cataract prevention for the elderly
and myopia control for children and adolescents.
The Company has developed a hybrid online
and offline education system, collaborating with
professionals to provide accessible eye health
information. This initiative promotes proactive
prevention among students, parents, and seniors,
enhancing the reach and sustainability of eye
health services. It aligns with the national goal of
universal access to basic ophthalmic care, offering
a replicable model for "Healthy China".
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Product Responsibility
Eyebright Medical views product quality as critical to its operations, adhering to strict safety standards and
developing a sustainable supply chain. The Company optimizes its customer service to ensure that every
phase, from raw material procurement to delivery, meets the highest industry standards.
Quality Management
Eyebright Medical enhances its quality and safety management systems through a focus on organizational
structure, compliance, supervision, and training. This commitment ensures effective control over product
quality and safety, protecting patient health.
Quality Management System
Building upon the ISO9001 standard, the Company aligns its operations with a comprehensive framework
of domestic and international regulations, including ISO13485, the EU MDR, and GMP requirements for
Korea and Brazil (RDC665/2022). The Compnay continuously refines its organizational, institutional, and
supervisory frameworks by embedding quality risk management and control directly into its business
processes. Through the rigorous implementation of quality objectives and active engagement with
global regulators and third-party auditors, the Company ensures the robust and reliable operation of its Quality
Management System.
During the Reporting Period
ISO9001 ISO13485 KGMP
The company underwent 20 external audits
all passed on the first attempt, recorded
GB/T42061 RDC GMP
no significant product quality incidents, and
had seven products subject to national-level
Medical Device sampling inspections with qualified results.
EU MDR CE Certificate License
Eyebright Medical's CNAS testing center is accredited by the China National Accreditation Service for
Conformity Assessment (CNAS), making it the first private laboratory in China for intraocular lenses to
achieve this recognition. Equipped with advanced testing equipment, the center ensures robust support for
product quality and safety.
In December 2025, the Company contributed to the release of the
"Guidelines for Internal Risk Communication and Discussion on Quality and
Safety of Medical Device Manufacturers" under the ZGC Medical Devices
Innovation Alliance, underscoring its expertise in quality management.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Quality and Safety Control
Customer Service
The Company has implemented a "Risk
The capability and quality of service are central
Management Control Procedure" to systematically
to competitive advantage. Eyebright Medical is
identify, analyze, evaluate, and control product
committed to a customer-oriented approach and
safety risks. Regular assessments refine this
responsible marketing principles. The Company has
process, ensuring regulatory oversight across all
established comprehensive service management
stages of product R&D, production, and materials
systems, including the "Service Control Procedure"
management to maintain consistent and reliable
and the "Customer Feedback and Complaint
product quality.
Control Procedure", to actively incorporate
Non-Conformance Adverse Event feedback and enhance clients experience.
Control Procedure Control Team
Informed Product Recall
Service System Control Procedure
Communication Channels
During the Reporting Period
NO product safety or health-related recalls Market Online
The “400”
Customer Service
Research Services
Hotline
Quality Safety Training
Eyebright Medical emphasizes the enhancement of
employee quality awareness and skills as a central Intelligent Customer Customer
Self-Service Focus Satisfaction
aspect of quality management. The Company System Roundtable Surveys
offers targeted quality safety training, covering
professional knowledge, operational standards, The Company conducts biannual in-depth customer
legal regulations, industry standards, internal satisfaction surveys to identify potential issues,
controls, ethics, and case studies. This systematic allowing for targeted improvements, confirming its
training strengthens employees' understanding and commitment to continuous quality enhancement.
practical skills, establishing a solid foundation for
quality control and supporting sustainable growth. Customer Satisfaction Survey
Case
Average score: above 9.8
In 2025, the Company conducted satisfaction
surveys with agents and direct-selling hospitals,
assessing product usability, effectiveness, and
delivery processes. Participants reported an
overall average score exceeding 9.8, indicating
high satisfaction with the Company’s products.
During the Reporting Period
NO significant customer complaints
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Sustainable Supply Chain
Supplier Management
Eyebright Medical prioritizes supplier management as an extension of its corporate values, guided by
three principles, including Strict Selection of Quality Suppliers, Long-term Strategic Partnerships and Social
Responsibility and Environmental Awareness.
The Company implements a "Procurement Control Procedure" to
Tiered
Management categorize suppliers and materials into ABC tiers based on risk,
qualifications, and quality, enabling dynamic evaluations.
The Company maintains a record of qualified suppliers, prioritizing
Evaluation
System those with ISO14001, ISO45001, and ISO50001 certifications to enhance
environmental and safety management.
The Company’s "Key Supplier On-site Inspection System" assesses
On-site
Inspections critical suppliers' environments, quality systems, and delivery
capabilities.
Responsible Procurement
Sign
Agreements
Assess
Demands
Establish
Procedures
The Company formalizes demand planning and
supplier agreements, including a "Medical Device During the Reporting Period
Quality Assurance Agreement" that specifies NO incidents of returned goods due to
liability and risk notification clauses to ensure procurement inspection issues were reported
product quality.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Employee Development
Eyebright Medical considers its employees the most valuable asset, upholding a culture of innovation,
openness and harmony, honesty, and sharing success. Committed to fostering a diverse workplace, the
Company provides opportunities for employees to demonstrate their talents and enhance creativity, aligning
individual aspirations with corporate objectives.
Employees Rights and Interests
Compliance with Employment Regulations
Eyebright Medical adheres to principles of equality and inclusivity in hiring, strictly following the Labor Law
of PRC and related regulations. Clear processes are established to ensure fairness and protect the rights of
employees and candidates.
The Company employs a diverse recruitment strategy, including online platforms, campus recruitment, and
internal referrals to attract top talent. To encourage employee involvement, the "Bole Award" is offered to
reward successful talent referrals, fostering a robust talent acquisition ecosystem.
As of the end of the Reporting Period
The Company has a total of 2,331 employees
Gender Distribution Age Distribution Ethnic Distribution
Female Male years years years years
and and Minority ethnic groups
below above
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Inclusive Workplace
Eyebright Medical is dedicated to fairness in recruitment, training, and promotion, ensuring equal treatment
for employees of diverse backgrounds, including region, ethnicity, age, gender, religion, and culture.
The Company prioritizes the protection of women’s Percentage of Female Executive
rights, adhering to relevant laws to provide
equitable opportunities and career development.
Eyebright Medical actively fosters a supportive Male Executives
environment for women's professional growth. Female Executives
In alignment with government initiatives promoting
employment for individuals with disabilities,
Eyebright Medical offers tailored job opportunities
As of the end of the Reporting Period
and benefits, fulfilling its social responsibility. By
Female executives accounted for 50%
of the total
five individuals with disabilities.
Cultivation and Development
Compensation and Incentives
Eyebright Medical recognizes employee motivation as essential for sustained growth. The Company has
established a comprehensive compensation system, including salaries, performance bonuses, and equity
options, to enhance engagement and loyalty.
In 2025, the Company strictly followed legal requirements and board resolutions, implementing equity
incentives under the 2021 Restricted Stock Incentive Plan for eligible employees, thereby fostering
innovation and shared growth.
During the Reporting Period
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Promotion Mechanism
Eyebright Medical values employees and uses a dual-track promotion system to meet business needs
and provide clear career paths. The Company promotes a culture of efficient, fair performance, using a
performance management system aligned with business goals, measuring both company achievements
and individual contributions.
In 2025, the Company assigned employees to roles in Key Performance Indicators
subsidiaries, strengthening management and technical
capabilities and promoting cultural integration. Work Attitudes Work Plans
Talent Development
Eyebright Medical prioritizes employee skills development and career growth. Training is central to its HR
strategy, following “empowering employee growth to support strategic implementation.” With integrated
resources and a dual-driven system, it ensures continuous learning and improvement, creating a positive
learning culture.
Headquarters
Training in 224 17,536 5,269
Total training sessions Total training hours Total participants
Leadership Training
Peking University Economic Management Training Program
The Peking University Economic Management Training Program
ran from August 2024 to July 2025, empowering managers and
receiving positive feedback. The second phase began in October
managerial capabilities and promoting partner collaboration.
Business and Management Synergy
By emphasizing "knowledge extraction, contextual transformation,
and precise empowerment", this initiative, the program has
received broad approval from participants, promoting individual
capabilities, team collaboration, and organizational development,
thus strengthening the Company's production system and core
competitiveness.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Expert Lecture Series General Skills Training
In 2025, the Company launched the Expert Lecture Series, In 2025, the Company
conducting 12 in-person training sessions throughout the provided ongoing general skills
year. These sessions integrate market insights, customer training on onboarding, digital
needs, and technological development. This initiative capabilities, collaboration,
enhances the industry perspective and business acumen of and compliance. This
R&D personnel, aligning technology with market demands. helped employees grow
Furthermore, it fosters departmental collaboration and comprehensively and
encourages cross-disciplinary innovation, supporting the strengthened the Company’s
Company’s sustainable development. talent foundation.
Professional Skills Training Internal Knowledge Sharing
The Company emphasizes
the importance of knowledge
management and experience
sharing. A group of internal
trainers has been developed to share expertise on
Targeted training in lean production
new product launches, legal fundamentals, and tax
and quality management tools was
knowledge, promoting effective information flow and
provided, improving the capabilities
ensuring operational efficiency.
and efficiency of staff.
New Employee Onboarding Training
During the Reporting Period, the Company organized regular onboarding training
for new employees to convey corporate culture and behavioral guidelines. This
program fosters a sense of belonging and identity, facilitating the transition from
industry newcomers to valued members of the corporate community. The training
is designed with a focus on "cognitive empowerment and emotional cohesion",
addressing strategic awareness, role clarification, cultural alignment, and team
bonding, thereby laying a solid foundation for mutual growth.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Welfare and Care
Employee Benefits
The Company prioritizes employee health management by adhering to legal requirements and offering
additional benefits such as supplementary medical insurance, health check-ups, annual leave, holiday gifts,
and Beijing residency permits. These diverse welfare measures enhance employee development, well-being,
and overall sense of belonging.
Pension insurance, work injury Insurance, unemployment insurance,
maternity insurance, medical insurance
Statutory
Benefits Housing provident fund
Statutory holidays and paid leave
Supplemental medical insurance, annual health checkups, specific disease
screening for female employees, care leave for female employees
Employee assistance program (EAP)
Company Beijing residency permits
Benefits Meal subsidies, holiday gifts, special allowances
Free shuttle service, nursing facilities, gym, basketball court, and cafeteria
Awards for innovation, patents, outstanding performance, and distinguished
contributions
Democratic Communication
The Company values employee feedback and promotes an open communication culture. It utilizes various
channels to understand employee needs and has an internal information-sharing system for timely
responses. Continuous process optimization and work environment improvements enhance employee
satisfaction and foster a positive corporate culture.
Multi-Channel Communication Mechanisms
Employee Congress & Executive Committee: Regular meetings and proposal systems to safeguard and oversee employee rights
Management Feedback Mechanism: Employee input is solicited at annual R&D, sales, operational and management meetings
Employee Relations Specialists: Manage communication channels, provide labor coordination and career planning support
Executive & Audit Visits: Multi-level engagement to collect employee feedback
Internal Company Journal: Highlight employee accomplishments and foster internal culture sharing
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Work-Life Balance
The Company prioritizes work-life balance by creating an employee-centered support system that addresses
diverse needs. It organizes various activities to enrich employees' cultural and spiritual lives, promoting
balance between work and personal life.
Create a “diverse and friendly” workplace environment.
To meet diverse needs, the Company has
established a nursing room for breastfeeding
mothers, built basketball courts and gyms
for fitness enthusiasts, and provided shuttle
services covering major residential areas
and transport hubs to ease commuting.
Case
World Book Day Events
For the fourth years, Eyebright has celebrated
World Book Day by gifting books to employees'
children, promoting core values and fostering a
love for reading among over 350 families.
Sport Events
The second Sport Day featured nearly 40
matches, promoting physical fitness and
enhancing interdepartmental collaboration.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Case
Fifth Employee Photography Contest
Themed “Pictures of Light, Dreams in Vision ”,
the contest received nearly a thousand entries,
showcasing the beauty of Eyebright and life,
contributing to the Company’s legacy for 2025.
All employees reflected on 15 years of
achievements and envisioned a bright future,
enhancing team cohesion. All employees
gathered to celebrate our achievements,
look ahead with confidence, and mark this
milestone as we begin a new journey for the
next 15 years.
The Huzhou excursion was designed to
strengthen collaboration and provide
employees with an opportunity to relax and
connect.
Sales Department Family Day
The Company’s Marketing Department hosts
annual Family Day events to strengthen team
cohesion and bridge the gap between work
and home. These activities offer families a
glimpse into our corporate culture, fostering a
harmonious and supportive work environment
through engaging interactions.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Subsidiary Activities Highlights
Annual Conference & 10 th Anniversary Celebration
International Women's Day Floral Workshop Fun Sports Day Team Building Qixi Festival Lacquer Fan Workshop
Badminton Tournament Dragon Boat Festival Celebration Lantern Festival Crafting Workshop
Team-Building Trip to Linyi Mid-Autumn Festival Garden Party
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Occupational Health and Safety
Occupational Health and Safety
Eyebright Medical is committed
Health and Safety Safeguards
to employee health and safety,
adhering to national and
international regulations, including
the Work Safety Law of PRC and
achieved ISO45001 Occupational
Health and Safety Management Occupational Standardized Routine Training Safety Culture
System certification. It continuously Health Monitoring Procedures Programs Cultivation
invests in resources to enhance
During the Reporting Period
safety management and provide a
secure work environment. NO safety or occupational health incidents occurred.
Safety Production
Eyebright Medical strictly implements the safety production policy of
"Safety First, Prevention Foremost, and Comprehensive Governance".
By reinforcing safety responsibilities and standardizing management
practices, the Company has elevated its overall safety performance,
effectively mitigating production accidents and occupational diseases to
ensure sustainable growth. Eyebright Medical has achieved Level 3 Work
Safety Standardization Certificate.
Safety Prevention Comprehensive
First Foremost Governance
The Company prioritizes safety education, conducting regular training
on production safety, fire prevention, and emergency evacuation to
enhance employee safety awareness and proficiency.
Emergency Management
To standardize emergency responses, the Company has established a Work Safety Incident Emergency Plan
comprising comprehensive, specialized, and on-site protocols. Supported by dedicated emergency supplies,
regular drills in fire, chemical, and biological safety are conducted to enhance employee readiness and
minimize potential losses.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Serve the Society
Enterprises play a vital role in society, and serving community needs is their duty. Eyebright Medical
integrates social responsibility into its development strategy, actively engaging in philanthropy and rural
revitalization initiatives, and aspires to be a model of humanistic care and social commitment.
Rural Revitalization
While advancing core business, the Company upholds a long-term vision to support rural revitalization,
prioritizing improvements in infrastructure, basic livelihood security, and the cultivation of specialty
industries.
Partnership for Rural Revitalization Road Improvement Initiative
In 2025, the Company supported rural revitalization In 2025, the Company donated funds to the
in Ar Horqin Banner, Inner Mongolia, by pairing villagers’ committee of Xiayuan Village, Leping
with three villages and funding key infrastructure Town, Pingba District, Anshun, Guizhou, to
projects including agricultural storage, feed support the road widening and upgrade project.
equipment maintenance, and community greening. The donation aims to improve transportation
infrastructure and help fully resolve residents’
travel difficulties.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
International Aid Initiatives
Eyebright Medical is dedicated to advancing
global eye health through the "Belt and Road"
international cooperation. The Company provides
high-end ophthalmic devices, including intraocular
lenses and injectors, for the "Guangming Xing"
(Light Journey) missions.
Eyebright Medical collaborated with Chinese
medical teams on "Belt and Road" projects across
Morocco, Fiji, Cambodia, Equatorial Guinea,
Uzbekistan, Kyrgyzstan, and Ethiopia. By providing
domestically developed premium products-
including IOLs, viscoelastic, and surgical blades-the
Company enabled patients to regain clear vision,
contributing to the building of a global community
of health for all.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Medical Donation
Aligning with the "Healthy China" strategy,
Eyebright Medical leverages its strengths to
conduct grassroots medical aid initiatives,
donating intraocular lenses and surgical supplies
to underserved patients in remote areas, thereby
consolidating rural revitalization achievements.
Throughout the Reporting Period, the Company
donated surgical supplies including intraocular
lenses, viscoelastic, and surgical blades, as well
as reading glasses to multiple regions, including
Qinghai, Jilin, Ningxia, Yunnan, Tibet, Gansu,
Shanxi, Sichuan, Xinjiang, Henan and Hainan,
bringing hope and light to patients in need.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Public Welfare and Charity
Eyebright Growth
Partnership Series
In celebration of International Children's
Day, Eyebright Medical, in collaboration with
the China Charity Federation, hosted the
"Eyebright Accompanies Your Growth" event
at the Central Primary School in Madian Town,
Henan, providing care packages and holiday
wishes to students
Eyebright Medical conducted the "Illuminating
V i s i on w i t h L o v e " c h a r i t y e v e n t a t t he
Xiaojudeng Children’s Rehabilitation Education
Center in Beijing, celebrating Mid-Autumn
Festival with children by offering warm
greetings and companionship.
Prior to New Year's Day, Eyebright Medical
held the "Illuminating Vision with Love"
New Year charity event at the Huicongshu
Children's Rehabilitation Institute and RY
Community Learning Center, delivering
essential supplies and engaging children in
festive activities.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Support for Overseas Chinese
Before the Dragon Boat Festival, Eyebright Medical
partnered with the Beijing Overseas Chinese Service
Center for the "Fragrant Zongzi and Patriotic Heart"
initiative, providing care packages and greetings to
elderly overseas Chinese community members.
Before the Double Ninth Festival, Eyebright Medical
collaborated with the Beijing Overseas Chinese
Service Center to offer eye health education and sent
warm wishes to elderly members of the community.
Eyebright Medical donated funds to the Beijing
Overseas Chinese Charity Foundation to support the
closing cultural exchange event on Overseas Chinese
Modernization, advancing cultural programs for the
overseas Chinese community.
Elder Care Initiatives
Eyebright Medical donated to the Shanghai Charity Foundation’s
"Filial Piety and Elder Care" program. This funding empowers
medical teams to deliver authoritative TCM knowledge directly to
seniors, demonstrating its deep commitment to elderly care.
Firefighter Greetings Activity
Eyebright Medical paid a visit to the Fire and Rescue Brigade of Ganyu
District, Lianyungang City, Jiangsu Province. The Company extended festive
greetings and gifts to all firefighters and commanders who have long been
dedicated to emergency rescue and safeguarding public safety, expressing
high respect and heartfelt thanks for their selfless contribution.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Scientific Popularization
Eyebright Growth
Partnership Series
Back-to-School Eye Care Open Day
During the Reporting Period, Eyebright Medical
initiated the 2025 Back-to-School Eye Care
event at its Beijing headquarters. Guided
by the Beijing Municipal Medical Products
Administration's Fourth Division, the program
engaged multiple families of iBright users.
Professor Yu Jifeng from the National Children's
Medical Center presented a lecture, while R&D
scientists outlined the principles for selecting
myopia prevention products for children,
highlighting the importance of individualized
approaches under professional supervision.
New Year Vision Helath
Eyebright Medical organized the "Welcoming
the New Year-Eye Health Awareness" event,
inviting children and adolescents to the
Company for educational lectures, vision tests,
and discussions on corrective lens experiences.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Community Outreach Program
To enhance community ophthalmic health and
reduce the incidence of blindness-causing
diseases, Eyebright Medical partnered with
ophthalmology experts from Changping District
Hospital. This initiative, held in the Huojiaying
community, featured educational lectures,
cataract screenings, and myopia prevention
efforts, offering residents valuable eye health
information at their doorstep.
Community Outreach Program
On National Sight Day, Eyebright Medical
hosted the "Healthy Eyes Foster a Bright
Future" outreach at School of Economics
and Management, Tsinghua University. By
translating cutting-edge ophthalmic insights
into actionable care, the initiative empowered
faculty and staff with enhanced awareness
and scientific eye protection skills.
Community Outreach Program
In response to the Ministry of Science and
Technology and local authorities, Eyebright
Medical established an educational e-station at
Nanshao Central Primary School in Changping
District, promoting scientific literacy and
awareness through engaging activities.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Governance
Eyebright Medical strictly complies with relevant laws, regulations,
and normative guidelines to advance corporate governance.
The Company continuously improves its governance structure,
standardizes internal controls and risk management mechanisms,
protects the rights of shareholders and investors, upholds business
ethics, and prioritizes information security and privacy protection
to safeguard high-quality development.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Corporate Governance
Leveraging a robust corporate governance structure and operating mechanisms, Eyebright Medical actively
builds a scientific, efficient, and forward-looking governance system. The Company continuously advances
compliance management, and enhances its ability to manage and operate in accordance with the law. It
increases transparency in communication with the capital market to foster mutual trust and long-term value
growth.
Governance Structure
In accordance with the Company Law, Securities Law of PRC, and Rules Governing the Listing of Stocks on
the STAR Market of the Shanghai Stock Exchange, the Company maintains a robust internal governance
framework comprising the General Meeting of Shareholders, Board of Directors, and Senior Management.
During the Reporting Period, the Board consisted of nine members, including six Non-Independent Directors
and three Independent Directors. The Board oversees business operations, strategic planning, and internal
organizational structure. It is supported by four specialized committees: the Audit Committee, Strategy
Committee, Compensation and Assessment Committee, and Nomination Committee. All Board and committee
members possess relevant industry experience and professional knowledge, regularly participating in
diverse training programs to enhance their competencies.
General Meeting of Shareholders
Board of Directors
Compensation
Strategy Audit Nomination
and Assessment
Committee Committee Committee
Committee
General Manager’s Office
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Board and Management Operations
Independence Specialization
The Company continuously improves its The Board of Directors has set up four
modern management mechanism. During the special committees. Members maintain
Reporting Period, it revised internal control rigorous meeting attendance, engage in
systems. The Company also formulated systematic review of management reports,
the Independent Director Work System. and conduct robust oversight through critical
Independent Directors are required to submit evaluation processes. Their structured
the Self-inspection Report to the Board, advisory input ensures Board deliberations
ensuring that independent directors meet incorporate multidimensional expertise,
requirements for "independence". thereby enhancing decision-making quality
and governance efficacy.
Diversity
The Company is committed to Board diversity. In selecting
DuringDirectors, it evaluates
the Reporting Period candidates based on
diversified criteria-including professional qualifications, industry background, and work experience-to
Female members accounted for
meet enterprise development needs. Board members deliver informed perspectives and well-founded
of
the Board.
recommendations that enhance the Company's governance framework and strategic oversight.
The senior management team covers During the Reporting Period
professional fields such as materials science,
optics, sales and financial accounting, and has
Female members accounted for 50% of
senior management.
rich experience in R&D, operation management,
financial management and other aspects.
Enhancement of Competency
During the Reporting Period
The Company regularly organizes Directors and Senior
Board members participated in
Management to participate in training hosted by regulatory
over
authorities and industry associations.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Effectiveness
Eyebright Medical continues to strengthen the roles of the shareholders' meeting. This ensures
scientific, effective, and transparent processes in major decision-making, daily operations, and
compliance supervision.
During the Reporting Period
Attendance rates for Directors at Board meetings and committee members at specialized
committee meetings reached 100%
Board meetings proposals Supervisory proposals
held with approved Committee approved
meetings with
Specialized proposals Shareholders’ proposals
Committee approved meeting held approved
meetings held with with
NO proposals were vetoed
Information Disclosure
The Company strictly follows the Rules Governing the
Listing of Stocks on the STAR Market of the Shanghai
Stock Exchange and other relevant laws and regulations. It
strengthens the management of information disclosure to
ensure the authenticity, accuracy, completeness, timeliness
and compliance of information disclosure. The Company
continuously improves the quality and transparency of
information disclosure, and effectively protects the rights and
interests of all shareholders, especially minority shareholders.
Disclosure Performance During the Reporting Period 3 Consecutive Years of A
-Level
Disclosure Rating
Shanghai Stock Exchange
Regular Reports Interim Announcements
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Investor Relations Management
Investor Communication
The Company values
the concerns of market
participants. To strengthen
investor relations
management, the Company
has formulated the Investor
Relations Management
System to improve
communication efficiency
and professionalism. It
also added an "Investor
Relations" column on the
official website and WeChat
official account for easy
access to information.
During the Reporting Period
Earnings Conferences: 6 periodic report performance briefings were held through multiple
online platforms
SSE E-Interaction Platform: 80 investor questions were answered with a 100% response rate
Investor Open Days: Hosted the "Shareholders Are Coming – Investors Visit Eyebright Medical"
event, with over 80 investors attending
International Exposure: Became the only medical device listed company of the 25th China
International Fair for Investment and Trade
performance comments reviews, and 30+ reports gave rating such as "Buy" and "Overweight"
respectively
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Investor Protection
Investor Returns
The Company holds the shareholders' general
Eyebright Medical attaches great importance to
meeting in compliance with the laws and
investor returns and has actively carried out cash
regulations, safeguards the shareholders' rights. It
dividends since its listing. During the Reporting
actively listens to investor suggestions on corporate
Period, the Company implemented a distribution
governance and sustainable development.
plan of RMB 3.50 per 10 shares (tax included).
Through initiatives such as the "2025 World
Total cash dividends amounted to
Investor Week", the Company helps investors better
understand market rules, risks, and opportunities, RMB67.64 million,
fostering a culture of value investing and long-term a 31.33% increase Y-O-Y
holding.
Completed a stock repurchase plan using self-
owned or raised funds
Brought back
of RMB 20.04 million
Market Capitalization
Management
Eyebright Medical places great emphasis on
market value management. Strictly following
the Guidelines for Listed Company Supervision
No. 10-Market Value Management, the Company
legally employs diversified tools to ensure its
investment value rationally reflects its quality.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Risk Management and Control
The Company has established a risk control system, continuously improved internal policies. By
systematically enhancing the ethical competence of all personnel, it strives to achieve long-term, stable,
healthy, and sustainable development.
Compliance and Internal Control Management
The Company prioritizes the construction of an internal control and compliance management system
tailored to its business scope and scale. It has established and strictly implemented a dynamic update
mechanism, and timely revises and improves the systems according to the changes in laws, regulations, and
regulatory policies.
The Company attaches importance
to the implementation of compliance
management. A transparent platform
disseminates compliance policies to
all employees (including subsidiaries)
to ensure consistent execution.
Related Party Transactions and Control
To ensure fairness and prevent harm to the During the Reporting Period
Company or minority shareholders, the Company
revised the Articles of Association and its Related
NO insider trading occurred
Party Transaction Decision-Making System during NO incidents infringed upon shareholder
the Reporting Period, It further standardized rights or caused asset loss
reporting, abstention, decision-making authority,
NO situations harmed the interests of the
and disclosure requirements. Related parties
Company or non-related shareholders
abstained from voting on relevant proposals.
During the Reporting Period, periodic reviews were
conducted, and no related-party transactions
requiring submission to the Board of Directors or
shareholders’ meeting occurred.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Management of Public Opinion
In the medical device industry, any
quality or safety incidents related to Monitoring Channels
the manufacturing, distribution, or sale
of medical devices are prone to attract
widespread media attention. It has
formulated the Reputation Management
System to address reputational risks.
This system enhances the ability to Websites Apps
identify, assess, monitor, and respond to
reputational risks, minimizing negative
impacts and protecting brand value.
During the Reporting Period
NO major public opinion incidents Forums Newspaper others
occurred
Anti-Fraud and Anti-Corruption Measures
Eyebright Medical upholds "Integrity and Practicality" During the Reporting Period
as one of its core values, strictly following the laws, and
NO related issues were reported
adheres to business ethics. The Company continuously
improves the business ethics and anti-corruption
NO significant corruption incidents
occurred
management system with institutional constraints.
Sound anti-corruption
policy framework
主要措施
Conduct integrity training and
Strengthened audit and
promote the full participation of
supervision intensity
all staff in anti-corruption work
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Anti-Unfair Competition Practices
Eyebright Medical promotes a fair market environment by strictly adhering to the Anti-Unfair Competition
Law of PRC. It has established a full-cycle anti-unfair competition management system to ensure the
elimination of unfair competition acts in business activities.
Fair competition criteria are integrated into employee conduct codes. All employees are required to maintain
integrity when interacting with competitors, customers, and suppliers.
During the Reporting Period
Conducted trainings on the Code of Business for new employees with a 100% training coverage rate
NO unfair competition lawsuits occurred
Reporting Mechanism
The Company has established a robust complaint and reporting mechanism, encouraging employees,
suppliers, and stakeholders to report unethical behavior via phone, email, or mail.
The Company strictly protects the confidentiality of
Reporting Channels
whistleblowers' identities and reported information.
It enforces stringent whistleblower protection Telephone：(86)10-60745730
protocols to safeguard identities and reported
Email：contact@ebmedical.com
content through multilayered confidentiality
safeguards.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Information Security & Data Privacy Protection
The Company prioritizes information security and privacy protection by enforcing comprehensive network
and computer management policies and building a comprehensive and efficient information system. This
system safeguards data security and confidentiality, and ensures stable operations.
Information Security and Digital Capability
Building
Conducted AI skills training to empower
Training all staff and improve compliance in
information processing
Added security features such as sensitive
System
Upgrade
information interception to ensure the
safety of the system
Team The IT team provides specialized support
support to any security issues
Customer Privacy Protection
Information Security Management
To ensure security throughout the process,
Strictly following the Cybersecurity Law and Data the Company has implemented rigorous
Security Law of PRC, the Company has built a controls:
systematic threat prevention and control loop. Embedded confidentiality clauses in
cooperation agreements or signed separate
Main Measures NDAs
Clearly defined data protection responsibilities
Multi-level intelligent firewall
Restricted both parties to abide by the
system
confidentiality agreement
Anti-virus software coverage
Network malware monitoring and
Case
blocking
Regular vulnerability management The CRM system and Cloud System strictly
safeguard the privacy data of customers
Rapid deployment and verification
of high-risk patches and other partners. Adhering to the principle
Business-level whitelist firewall of data minimization, the Company limits
Full-link network security the scope of collecting partners' and
monitoring platform personal information.
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Appendix
Index of Guildlines
Appendices GRI Standard
GRI Standard Disclosure ID GRI Standard Disclosure Topic Report Section
General Disclosure
GRI2：General Disclosures
GRI 2-1 Organization Detail About the Report
GRI 2-2 Entities Included in the Organization’s Sustainability Report About the Report
GRI 2-3 Reporting Period, Frequency and Contact Point About the Report
GRI 2-4 Restatements of Information /
GRI 2-5 External Assurance Statement of the Board Dircetors
GRI2：Activities and Workers
GRI 2-6 Activities, Value Chain and other business Relationships About Us
GRI 2-7 Employee Employee Development
GRI 2-8 Non-employee workers /
GRI2：Governance
GRI 2-9 Governance Structure and Composition Corporate Governance
GRI 2-10 Nomination and Selection of the Highest Governance Body Corporate Governance
GRI 2-11 Chair of the Highest Governance Body Corporate Governance
Role of the Highest Governance Body in Overseeing the
GRI 2-12 Corporate Governance
Management of Impacts
GRI 2-13 Delegation of Responsibility for Managing Impacts Corporate Governance
GRI 2-14 Role of the Highest Governance Body in Sustainability Report Statement of the Board Dircetors
GRI 2-15 Conflict of Interests Stakeholder Communication
GRI 2-16 Communication of critical concerns Stakeholder Communication
GRI 2-17 Collective knowledge of the highest governance body Corporate Governance
GRI 2-18 Evaluation of the performance of the highest governance body Corporate Governance
GRI 2-19 Remuneration Policies Corporate Governance
GRI 2-20 Process to determine remuneration /
GRI 2-21 Annual Total Compensation Ratio /
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Appendices GRI Standard
GRI Standard Disclosure ID GRI Standard Disclosure Topic Report Section
General Disclosure
GRI2：Strategy, Policies and Practices
GRI 2-22 Statement on Sustainable Development Strategy ESG Strategic Planning
Pollution Prevention, Employee
GRI 2-23 Policy Commitment
Development, Corporate Governance
GRI 2-24 Embedding Policy Commitments Employee Development
GRI 2-25 Processes to Remediate Negative Impacts Risk Management
GRI 2-26 Mechanisms for Seeking Advice and Raising Concerns Stakeholder Communication
GRI 2-27 Compliance with Laws and Regulations Risk Management
GRI 2-28 Membership Associations Collaborative Industry Advancement
GRI2：Stakeholder Engagement
GRI 2-29 Approach to Stakeholder Engagement Stakeholder Communication
GRI 2-30 Collective Bargaining Agreements Employee Development
GRI3：Material Topics
GRI 3-1 Process to Determine Material Topics Materiality Assessment
GRI 3-2 List on Material Topics Materiality Assessment
GRI 3-3 Management on Material Topics Materiality Assessment
Economic
GRI201：Economic Performance
GRI 201-1 Direct Economic Value Generated and Distributed Corporate Governance
GRI 201-2 Financial Implications and Other Risks and Opportunities due Employee Development
GRI 201-3 Defined Benefit Plan Obligations and Other Retirement Plans Climate Action
GRI203：Indirect Economic Impacts
Topic management disclosures Serve The Society
GRI 203-1 Infrastructure Investments and Services Supported Serve The Society
GRI 203-2 Significant Indirect Economic Impacts Serve The Society
GRI205：Anti-Corruption
Topic management disclosures Risk Management
GRI 205-1 Operations Assessed for Risks Related to Corruption /
GRI 205-2 Communication and Training About Anti-Corruption Policies Risk Management
GRI2016：Anti-Unfair Competition
Topic management disclosures Risk Management
Legal Actions for Anti-unfair Competition, Anti-trust, and
GRI 206-1 Risk Management
Anti-monopoly Practices
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Appendices GRI Standard
GRI Standard Disclosure ID GRI Standard Disclosure Topic Report Section
Environment
GRI301：Material
Topic management disclosures Resources Management
GRI 301-2 Recycled Input Materials Used Resources Management
GRI 301-3 Reclaimed Products and Their Packaging Materials Resources Management
GRI302：Energy
Topic management disclosures Resources Management
GRI 302-1 Energy Consumption within the Organization Climate Action
GRI 302-3 Energy Intensity Climate Action
GRI 302-4 Reduction of Energy Consumption Climate Action
GRI 302-5 Reductions in Energy Requirements of Products and Services Resources Management
GRI303：Water and Effluents
GRI 303-1 Interactions with Water as a Shared Resource Resources Management
GRI 303-2 Management of Water Discharge Related impacts Resources Management
GRI 303-3 Water Withdrawal Resources Management
GRI 303-4 Water Discharge Pollution Prevention
GRI 303-5 Water Consumption Resources Management
GRI305：Emissions
Topic management disclosures Climate Action
GRI 305-1 Direct (Scope 1) GHG Emissions Climate Action
GRI 305-2 Energy Indirect (Scope 2) GHG Emissions Climate Action
GRI 305-4 Other Indirect (Scope 3) GHG Emissions Climate Action
GRI 305-7 Nitrogen Oxides (NOx), Sulfur Oxides (SOx), and Other /
GRI306：Waste
GRI 306-1 Waste Generation and Significant Waste-Related Impacts Pollution Prevention
GRI 306-2 Management of Significant Waste Related Impacts Pollution Prevention
GRI 306-3 Waste Generated Pollution Prevention
GRI 306-4 Waste Diverted from Disposal /
GRI 306-5 Waste Directed to Disposal /
GRI308：Supplier Environmental Assessment
Topic management disclosures Product Responsibility
GRI 308-1 New Suppliers that were Screened Using Environmental /
GRI 308-2 Negative Environmental Impacts in the Supply Chain and
/
Actions Taken
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Appendices GRI Standard
GRI Standard Disclosure ID GRI Standard Disclosure Topic Report Section
Social
GRI401：Employment
Topic management disclosures Employee Development
GRI 401-1 New Employee Hires and Employee Turnover Employee Development
Benefits Provided to Full-Time Employees that are not
GRI 401-2 Employee Development
Provided
GRI402：Labor/Management Relations
Topic management disclosures Employee Development
GRI403： Occupational Health and Safety
Topic management disclosures Employee Development
GRI 403-1 Occupational Health and Safety Management System Employee Development
GRI 403-2 Hazard Identification, Risk Assessment, and Incident Survey Employee Development
GRI 403-3 Occupational Health Services Employee Development
GRI 403-4 Worker Training on Occupational Health and Safety Employee Development
GRI 403-5 Training of Worker Health Employee Development
GRI 403-6 Promomtion of Worker Health Employee Development
GRI 403-7 Prevention and Mitigation of Occupational Health and Safety Employee Development
GRI 403-8 Health and Safety Management System Employee Development
GRI 403-9 Work-related Injuries Employee Development
GRI 403-10 Work-related Ill Health Employee Development
GRI404：Training and Education
Topic management disclosures Employee Development
GRI 404-1 Average Hours of Training per Year per Employee Employee Development
Programs for Upgrading Employee Skills and Transition Employee Development
GRI 404-2
Assistance Programs
Percentage of Employees Receiving Regular Performance
GRI 404-3 Employee Development
and Career Development Reviews
GRI405：Diversity and Equal Opportunity
Topic management disclosures Employee Development
Employee Development,Corporate
GRI 405-1 Diversity of Governance Bodies and Employees
governance
GRI 405-2 Ratio of Basic Salary and Remuneration of Women to Men Employee Development
GRI406：Non-Discrimination
Topic management disclosures Employee Development
GRI 406-1 Incidents of Discrimination and Corrective Actions Taken Employee Development
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Appendices GRI Standard
GRI Standard Disclosure ID GRI Standard Disclosure Topic Report Section
Social
GRI407 ：Freedom of Association and Collective Bargaining
Topic management disclosures Employee Development
Operations and Suppliers in which the right to freedom of
GRI 407-1 /
Association and Collective Bargaining may be at Risk
GRI408：Child Labor
Topic management disclosures Employee Development
Operations and Suppliers at Significant risk for Incidents of
GRI 408-1 /
Child Labor
GRI409：Forced or Compulsory Labor
Topic management disclosures Employee Development
Operations and Suppliers at Significant risk for Incidents of
GRI 409-1 /
Forced or Compulsory Labor
GRI413：Local Communityv
Topic management disclosures Serve The Society
Operations with Local Community Engagement, Impact
GRI 413-1 Serve The Society
Assessments, and Development Programs
Operations with Significant Actual and Potential Negative
GRI 413-2 /
Impacts on Local Communities
GRI414：Supplier Social Assessment
Topic management disclosures Product Responsibility
GRI 414-1 New Suppliers that were Screened using Social Criteria Product Responsibility
GRI 414-2 Negative Social Impacts in the Supply Chain and Actions Taken /
GRI416：Customer Health and Safety
Topic management disclosures Product Responsibility
Assessment of the Health and Safety Impacts of Product
GRI 416-1 Product Responsibility
and Service Categories
Incidents of Non-Compliance Concerning the Health and
GRI 416-2 /
Safety Impacts of Products and Services
GRI417：Marketing and Labeling
Topic management disclosures Product Responsibility
GRI 417-1 Requirements for Product and Service Information and Labeling Product Responsibility
GRI 417-2 Incidents of Non-Compliance Concerning Product and Service /
GRI 417-3 Information and Labeling /
GRI418：Customer Privacy
Topic management disclosures Product Responsibility
Substantiated Complaints Concerning Breaches of Customer
GRI 418-1 /
Privacy and Losses of Customer Data
About the Board Chairman Performance Sustainability
About Us Environmental Social Governance Appendix
Report Statement Message Highlight Management
Guidelines No. 14 of Shanghai Stock Exchange for Self-Regulation of
Listed Companies- Sustainable Development Reports (Trial)
Dimension Topic Corresponding Chapter
Climate Change Action Climate Action
Pollutant Emissions Pollution Prevention
Waste Treatment Waste Treatment
Ecosystem and Biodiversity Protection Ecosystem and Biodiversity Protection
Environmental
Environmental Compliance Management Environmental Management
Energy Utilization Energy Management
Water Resource Utilization Resource Management
Circular Economy Resource Management
Rural Revitalization Rural Revitalization
Social Contribution Serve the Society
Innovation-Driven Development Innovation-Driven Development
Science and Technology Ethics Experimental Ethics
Social Supply Chain Safety Sustainable Supply Chain
Fair Treatment of SMEs Customer Service
Product and Service Safety and Quality Quality Management
Data Security and Privacy Protection Information Security & Data Privacy
Employees Employee Development
Due Diligence Sustainability Management
Stakeholder Communication Stakeholder Communication
Governance
Anti-Fraud and Anti-Corruption Anti-Fraud and Anti-Corruption Measures
Measures Anti-Unfair Competition Anti-Unfair Competition
首页
微信公众号
证券之星APP
